|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7048 USD | +5.37% |
|
+3.42% | -2.11% |
| Mar. 08 | Galecto, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Galecto Shares Climb After Bone Marrow Disease Treatment Trial Yields Positive Results | MT |
Aug 15 (Reuters) - Galecto Inc said on Tuesday it will dicontinue development of its lung disease treatment after it failed to meet its primary goal in a mid-stage study. (Reporting by Sriparna Roy in Bengaluru; Editing by Arun Koyyur)
| 1st Jan change | Capi. | |
|---|---|---|
| -2.11% | 19.11M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
GALECTO, INC. 
